Difference between revisions of "Talk:SUIT-006 MgG mt D055"
From Bioblast
| Line 1: | Line 1: | ||
{{Template:Chemicals SUIT-006 MgG mt D055}} | {{Template:Chemicals SUIT-006 MgG mt D055}} | ||
Revision as of 17:26, 2 September 2020
| Step | Chemical(s) and link(s) | Comments |
|---|---|---|
| 1PM | Pyruvate (P) and Malate (M) | Can be substituted by other combination of substrates |
| 2D | ADP (D) preparation for MgG assay | For this protocol, the ADP must be prepared without Mg2+ salts. |
| 3Cat | Carboxyatractyloside (Cat) | Can be substituted for oligomycin |
| 4U | SF6847 | Can be substituted for other uncoupler |
| 5Ama | Antimycin A (Ama) | Can be substituted for other CIII or CIV inhibitor |
| Chemical and link | Abbreviation | Chemical and link |
|---|---|---|
| Magnesium Green | MgG | |
| MgCl2 | Mg |
| Chemical and link | Abbreviation | Comments |
|---|---|---|
| Pyruvate | P | Can be substituted by other combination of substrates |
| Malate | M | Can be substituted by other combination of substrates |
| ADP | D | For this protocol, the ADP must be prepared without Mg2+ salts. |
| Carboxyatractyloside | Cat | Can be substituted for oligomycin |
| Uncoupler: in this DLP, SF6847 was used | U | Can be substituted for other uncoupler |
| Antimycin A | Ama | Can be substituted for other CIII or CIV inhibitor |
